Key facts
- This page summarizes David P. Schenkein's Form 4 filing for AGIOS PHARMACEUTICALS, INC. (AGIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Jun 2024, 17:29.
David P. Schenkein - 13 Jun 2024 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)
- Reporting relationship
- Director
- Issuer ticker
- AGIO
- Reported as of
- 13 Jun 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jun 2024, 17:29:37 UTC
- Prior SEC filing
- 14 Jun 2024
- Next SEC filing
- 24 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ William Cook, as Attorney-in-fact for David Schenkein
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David P. Schenkein filed Form 4 for AGIOS PHARMACEUTICALS, INC. (AGIO) on 17 Jun 2024.
Change
- Previous filing in this sequence was filed on 14 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AGIO
transaction
Common stock
Options Exercise
- Transaction value
- $0
- Shares
- +3,388
- Change %
- +2.8%
- Price
- $0.000000
- Shares after
- 126,242
- Date
- 13 Jun 2024
- Ownership
- Direct
AGIO
holding
Common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 270,772
- Date
- 13 Jun 2024
- Ownership
- See footnote
- Footnotes
- F1
AGIO
holding
Common stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 79,082
- Date
- 13 Jun 2024
- Ownership
- See footnote
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGIO
transaction
Derivative
Restricted stock units
Options Exercise
- Transaction value
- $0
- Shares
- -3,388
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Jun 2024
- Ownership
- Direct
- Underlying class
- Common stock
- Underlying amount
- 3,388
- Exercise price
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.
Footnote F2
Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.
Footnote F3
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
Footnote F4
The restricted stock units were granted on June 13, 2023. The shares underlying the stock units vest in full on June 13, 2024. Vested shares will be delivered to the reporting person within three business days after such shares become vested.